Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Infectious Diseases of Poverty|March 26, 2019
Detection of helminths by loop-mediated isothermal amplification assay: a review of updated technology and future outlookMiao-Han Deng, Lan-Yi Zhong, Okanurak Kamolnetr, et al.Signal Transduction and Targeted Therapy|June 28, 2022
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variantsCong Sun, Chu Xie, Guo-Long Bu, et al.Journal of Medical Virology|May 22, 2023
Anti-EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapyChu Xie, Lan-Yi Zhong, Guo-Long Bu, et al.Cell Reports|January 10, 2025
Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralizationCong Sun, Xin-Yan Fang, Guo-Long Bu, et al.Journal of Medical Virology|April 8, 2024
Evaluation of serum Epstein-Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseasesHui-Lan Li, Lan-Yi Zhong, Yin-Feng Kang, et al.Plos Pathogens|July 9, 2025
Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognitionChu Xie, Xin-Yan Fang, Yuan-Tao Liu, et al.Nature Communications|November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virusQian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.Medcomm|July 31, 2025
Applications of Artificial Intelligence in Biotech Drug Discovery and Product DevelopmentYuan-Tao Liu, Le-Le Zhang, Zi-Ying Jiang, et al.Science China. Life Sciences|November 6, 2024
Research landmarks on the 60th anniversary of Epstein-Barr virusLan-Yi Zhong, Chu Xie, Le-Le Zhang, et al.Signal Transduction and Targeted Therapy|October 9, 2024
AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separationDan-Ling Dai, Chu Xie, Lan-Yi Zhong, et al.Pageof 1